The announcement comes after the NYSE suspended Vicarious’ stock and initiated the delisting process in early March 2026.
Sunnyvale, California-based Prodeon designed Urocross as a novel, non-permanent implant technology for treating lower urinary ...
Lensar (Nasdaq:LNSR) announced today that it reached an agreement with Alcon (NYSE:ALC) to terminate their planned merger.
CMR Surgical today announced a new effort with Nvidia to train the next generation of intelligent surgical systems.
Pulsed field ablation technology developer Field Medical announced today that it has named Dr. Mark A. Turco as CEO, effective immediately.
Baxter (NYSE: BAX) announced today that EVP and CFO Joel Grade is departing the company and a search is underway for a replacement.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results